Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrimidines >  Aminopyrimidine >  5-AMINOPYRIMIDINE

5-AMINOPYRIMIDINE

Basic information Safety Supplier Related

5-AMINOPYRIMIDINE Basic information

Product Name:
5-AMINOPYRIMIDINE
Synonyms:
  • 5-AMINOPYRIMIDINE
  • PYRIMIDIN-5-AMINE
  • PYRIMIDIN-5-YLAMINE
  • 5-Pyrimidinamine (9CI)
  • 5-Pyrimidinamine
  • 5-AMINOPYRIMIDINE (MFCD
  • Pyrimidin-5-amine, 5-Amino-1,3-diazine
  • 5-Aminopyrimidine >
CAS:
591-55-9
MF:
C4H5N3
MW:
95.1
Product Categories:
  • Heterocycle-Pyrimidine series
  • PYRIMIDINE
  • 591-55-9
Mol File:
591-55-9.mol
More
Less

5-AMINOPYRIMIDINE Chemical Properties

Melting point:
171°C(lit.)
Boiling point:
240.7±13.0 °C(Predicted)
Density 
1.216±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Inert atmosphere,Room temperature
pka
2?+-.0.10(Predicted)
form 
powder to crystal
color 
White to Light yellow
λmax
315nm(EtOH)(lit.)
InChI
InChI=1S/C4H5N3/c5-4-1-6-3-7-2-4/h1-3H,5H2
InChIKey
FVLAYJRLBLHIPV-UHFFFAOYSA-N
SMILES
C1=NC=C(N)C=N1
More
Less

Safety Information

Hazard Codes 
Xi,Xn
Risk Statements 
22-36/37/38
Safety Statements 
26
WGK Germany 
3
HazardClass 
IRRITANT-HARMFUL
HS Code 
2933599590
More
Less

5-AMINOPYRIMIDINE Usage And Synthesis

Uses

5-Aminopyrimidine is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

Definition

ChEBI: Pyrimidin-5-amine is an aminopyrimidine.

Synthesis

53180-76-0

591-55-9

General procedure for the synthesis of 5-aminopyrimidines from 4-amino-3,5-dichloropyridazines: 5-amino-4,6-dichloropyridine (5.0 g, 30.5 mmol) was dissolved in 250 mL of diethyl ether, and sodium hydroxide solution (20.0 g, 0.50 mol, dissolved in 60 mL of water) and palladium-carbon catalyst (10% Pd/C, 400 mg) were sequentially added. The reaction mixture was placed in a Parr oscillator and the reaction was oscillated at room temperature under 50 psi hydrogen pressure for 20 hours. Upon completion of the reaction, the catalyst was removed by filtration through a CELITE filter aid. The organic and aqueous phases of the filtrate were separated and the aqueous phase was extracted with ethyl acetate (3 x 100 mL). The organic phases were combined, dried with magnesium sulfate, filtered and concentrated under reduced pressure. The crude product was recrystallized by ethyl acetate to give pyrimidin-5-ylamine (2.8 g, 95% yield) as a white crystalline solid. The bromination of pyrimidin-5-ylamine was carried out under the same conditions as for the preparation of 4-amino-3-bromo-2,6-dimethylpyridine. The crude product obtained (300 mg, 35% yield) was tested to be of sufficient purity to be used directly in the subsequent reaction. Steps for the alternative synthesis of 5-amino-4-bromopyrimidine: 4,6-dichloro-5-aminopyrimidine (21 g, 128 mmol) was dissolved in 250 mL of methanol, and ammonium formate (45 g, 714 mmol) and palladium-carbon catalyst (10% Pd/C, 1 g, 0.943 mmol) were added sequentially, and the reaction mixture was stirred at 0 °C overnight. Upon completion of the reaction, it was filtered through a CELITE filter aid and the filtrate was concentrated under reduced pressure to give a yellow solid. Water (100 mL) and ethyl acetate (250 mL) were added to separate the organic phase and the aqueous phase was extracted with ethyl acetate (8 x 250 mL). The organic phases were combined, dried with magnesium sulfate, filtered and concentrated under reduced pressure to give off-white crystals (8.1 g, 67% yield). 5-Aminopyridine (3.0 g, 31.5 mmol) was dissolved in a solvent mixture of dichloromethane (150 mL) and methanol (30 mL) and cooled to 0 °C. Benzyltrimethylammonium tribromide (13.5 g, 34.7 mmol) was added in batches over 10 minutes. The reaction mixture was continued to be stirred at 0 °C for 15 min and then brought to room temperature and stirred for 90 min. Upon completion of the reaction, the pH was adjusted with aqueous sodium bicarbonate to 8. The organic layer was separated and the aqueous layer was extracted with ethyl acetate (3 x 30 mL). The organic phases were combined, dried with sodium sulfate, filtered and concentrated under reduced pressure to give an off-white solid (2.8 g, 51% yield), which could be used without further purification.

Purification Methods

It is purified by conversion to the MgCl2 complex in a small volume of H2O. The complex (~ 5g) is dissolved in the minimum volume of hot H2O, passed through a column of activated Al2O3 (200g), and the column is washed with EtOH. Evaporation of the EtOH gives a colourless residue of the aminopyrimidine which is recrystallised from *C6H6 (toluene could also be used) which forms needles at first, then prisms. It melts with sublimation. Acetylation yields 5-acetamidopyrimidine which crystallises from *C6H6, m 148-149o. [Whittaker J Chem Soc 1565 1951.]

References

[1] Patent: WO2005/30213, 2005, A1. Location in patent: Page/Page column 176
[2] Patent: WO2005/30213, 2005, A1. Location in patent: Page/Page column 176-177

5-AMINOPYRIMIDINE Preparation Products And Raw materials

Raw materials

5-AMINOPYRIMIDINESupplier

Shanghai Jiezhen Pharmaceutical Technology Co., Ltd. Gold
Tel
15995055116
Email
815229059@qq.com
Hunan Daolin Biotechnology Co. , Ltd. Gold
Tel
18974846212
Email
1876969603@qq.com
Taizhou Wealsun Biotech Co., Ltd Gold
Tel
18351140886
Email
wealsunbio@126.com
SiChuang NanBu Honesty Technology Co., Ltd.
Tel
0838-5675166 15883665058
Email
nbcxkj@126.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com